Samrat Pharmachem [SAMRATPH] vs Chemplast Sanmar [CHEMPLASTS] Detailed Stock Comparison

Samrat Pharmachem Ltd.

BSE
Loading...

Chemplast Sanmar Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Samrat Pharmachem Ltd. wins in 14 metrics, Chemplast Sanmar Ltd. wins in 4 metrics, with 0 ties. Samrat Pharmachem Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Samrat Pharmachem Ltd. Chemplast Sanmar Ltd. Better
P/E Ratio (TTM) 39.68 210.40 Samrat Pharmachem Ltd.
Price-to-Book Ratio 0.98 2.02 Samrat Pharmachem Ltd.
Debt-to-Equity Ratio 15.49 96.73 Samrat Pharmachem Ltd.
PEG Ratio -0.34 1.47 Chemplast Sanmar Ltd.
EV/EBITDA -93.75 62.22 Chemplast Sanmar Ltd.
Profit Margin (TTM) -0.58% -7.01% Samrat Pharmachem Ltd.
Operating Margin (TTM) -1.33% -13.16% Samrat Pharmachem Ltd.
Return on Equity 9.91% -5.34% Samrat Pharmachem Ltd.
Return on Assets (TTM) 5.85% -1.70% Samrat Pharmachem Ltd.
Free Cash Flow (TTM) $-105.99M $-2.11B Samrat Pharmachem Ltd.
Dividend Yield 0.29% N/A N/A
1-Year Return -41.18% -53.14% Samrat Pharmachem Ltd.
Price-to-Sales Ratio (TTM) 0.24 0.95 Samrat Pharmachem Ltd.
Enterprise Value $597.84M $52.84B Chemplast Sanmar Ltd.
EV/Revenue Ratio 0.21 1.28 Samrat Pharmachem Ltd.
Gross Profit Margin (TTM) 2.59% 31.44% Chemplast Sanmar Ltd.
Revenue per Share (TTM) $936 $260 Samrat Pharmachem Ltd.
Earnings per Share (Diluted) $-5.42 $-18.05 Samrat Pharmachem Ltd.
Beta (Stock Volatility) -0.35 0.01 Samrat Pharmachem Ltd.

Samrat Pharmachem Ltd. vs Chemplast Sanmar Ltd. Stock Performance Analysis

Loading Price Chart...

SAMRATPH
CHEMPLASTS

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Samrat Pharmachem Ltd.0.55%-1.82%-3.65%-2.01%-20.44%-11.37%
Chemplast Sanmar Ltd.-0.85%2.62%-12.27%-23.76%-23.33%-21.41%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Samrat Pharmachem Ltd.-41.18%-54.10%-17.42%588.68%951.05%2,351.16%
Chemplast Sanmar Ltd.-53.14%-55.34%-62.63%-62.63%-62.63%-62.63%

Performance & Financial Health Analysis: Samrat Pharmachem Ltd. vs Chemplast Sanmar Ltd.

MetricSAMRATPHCHEMPLASTS
Market Information
Market Cap i₹676.34M₹38.60B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i1,760363,895
90 Day Avg. Volume i2,391432,557
Last Close₹201.85₹201.22
52 Week Range₹190.00 - ₹389.00₹193.11 - ₹477.75
% from 52W High-48.11%-57.88%
All-Time High₹1,250.00 (Sep 19, 2022)₹826.00 (Oct 11, 2021)
% from All-Time High-83.85%-75.64%
Growth Metrics
Quarterly Revenue Growth0.00%-0.21%
Quarterly Earnings Growth0.00%-0.21%
Financial Health
Profit Margin (TTM) i-0.01%-0.07%
Operating Margin (TTM) i-0.01%-0.13%
Return on Equity (TTM) i0.10%-0.05%
Debt to Equity (MRQ) i15.4996.73
Cash & Liquidity
Book Value per Share (MRQ)₹228.64₹122.81
Cash per Share (MRQ)₹62.79₹35.59
Operating Cash Flow (TTM) i₹1.26M₹-16,100,000
Levered Free Cash Flow (TTM) i₹71.12M₹-1,103,600,000
Dividends
Last 12-Month Dividend Yield i0.29%N/A
Last 12-Month Dividend i₹1.00N/A

Valuation & Enterprise Metrics Analysis: Samrat Pharmachem Ltd. vs Chemplast Sanmar Ltd.

MetricSAMRATPH (Apr 24, 2026)CHEMPLASTS (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i39.68210.40
Forward P/E iN/A35.91
PEG Ratio i-0.341.47
Price to Sales (TTM) i0.240.95
Price to Book (MRQ) i0.982.02
Market Capitalization
Market Capitalization i₹676.34M₹38.60B
Enterprise Value i₹597.84M₹52.84B
Enterprise Value Metrics
Enterprise to Revenue i0.211.28
Enterprise to EBITDA i-93.7562.22
Risk & Other Metrics
Beta i-0.350.01
Book Value per Share (MRQ) i₹228.64₹122.81

Financial Statements Comparison: Samrat Pharmachem Ltd. vs Chemplast Sanmar Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSAMRATPH (2025)CHEMPLASTS (2025)
Revenue/Sales i2.86B43.28B
Cost of Goods Sold i2.71B28.56B
COGS % of Revenue i94.7%66.0%
Gross Profit i152.75M14.72B
Gross Margin i5.3%34.0%
Research & Development i0N/A
Operating Income (EBIT) i97.54M530.00M
Operating Margin i3.4%1.2%
EBITDA i107.17M1.55B
EBITDA Margin i3.7%3.6%
Pre-Tax Income i98.86M-1.69B
Pre-Tax Income % of Revenue i3.5%-3.9%
Income Tax i27.74M-587.10M
Income Tax % of Revenue i1.0%-1.4%
Net Income (Profit) i71.12M-1.10B
Profit Margin i2.5%-2.5%

Balance Sheet & Liquidity Metrics

MetricSAMRATPH (2025)CHEMPLASTS (2025)
Cash & Equivalents i483,0005.55B
Total Current Assets i1.03B17.75B
Total Current Assets % of Revenue i36.2%41.0%
Total Current Liabilities i495.83M27.15B
Total Current Liabilities % of Revenue i17.3%62.7%
Long-Term Debt i011.02B
Long-Term Debt % of Revenue i0.0%25.5%
Total Shareholders Equity i718.00M20.68B
Retained Earnings i687.11M16.89B
Retained Earnings % of Revenue i24.0%39.0%
Property, Plant & Equipment i044.93B

Cash Flow Statement Comparison

MetricSAMRATPH (2025)CHEMPLASTS (2025)
Operating Cash Flow i1.26M-16.10M
Operating Cash Flow % of Revenue i0.0%0.0%
Capital Expenditures i-5.07M-3.60B
Free Cash Flow i-105.99M-2.11B
FCF Margin i-3.7%-4.9%
Debt Repayment iN/A-15.34B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSAMRATPHCHEMPLASTS
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i3.09M158.11M
Float Shares i1.19M61.38M
% Held by Insiders i59.26%54.99%
% Held by Institutions i0.00%36.24%
% Held by Public i40.74%8.77%

Dividend Analysis & Yield Comparison: Samrat Pharmachem Ltd. vs Chemplast Sanmar Ltd.

MetricSAMRATPHCHEMPLASTS
Last 12-Month Dividend i₹1.00N/A
Last 12-Month Dividend Yield i0.29%N/A
3-Year Avg Annual Dividend i₹1.67N/A
3-Year Avg Dividend Yield i0.17%N/A
3-Year Total Dividends i₹5.00N/A
Ex-Dividend DateSep 19, 2024N/A